Identification of Conserved Pappalysin 1-Derived Circular RNA-Mediated Competing Endogenous RNA in Osteosarcoma

Guang-Fu Ming1, Bo-Hua Gao1, Peng Chen1

  • 1Department of Orthopedics, Hainan General Hospital (Hainan Affiliated Hospital of Hainan Medical University), Haikou, China.

Insights

This study identifies key microRNAs (miRNAs), circular RNAs (circRNAs), and messenger RNAs (mRNAs) involved in osteosarcoma (OS) pathogenesis. The findings reveal a competing endogenous RNA (ceRNA) network crucial for OS development and potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Osteosarcoma (OS) etiology is complex and not fully understood.
  • MicroRNAs (miRNAs), circular RNAs (circRNAs), and messenger RNAs (mRNAs) play roles in cancer development.
  • Understanding regulatory networks like competing endogenous RNAs (ceRNAs) is vital for OS research.

Purpose of the Study:

  • To identify differentially expressed miRNAs, circRNAs, and mRNAs in osteosarcoma (OS) cell lines.
  • To investigate the mechanism of circRNA-associated competing endogenous RNAs (ceRNAs) in OS.
  • To build a ceRNA regulatory network for OS pathogenesis.

Main Methods:

  • Downloaded and analyzed microarray datasets for mRNA, miRNA, and circRNA expression in human OS cell lines.
  • Identified differentially expressed RNAs (DE RNAs).
  • Annotated DE mRNAs for Gene Ontology (GO) biological processes and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Identified DEcircRNA-mediated ceRNA mechanisms.

Main Results:

  • Identified 326 DEmRNAs, 45 DEmiRNAs, and 110 DEcircRNAs.
  • DEmRNAs associated with GO BP terms like angiogenesis and KEGG pathways including the p53 signaling pathway.
  • Constructed a ceRNA network involving 8 DEcircRNAs, 3 DEmiRNAs, and downregulated genes (MMP13, HMOX1).

Conclusions:

  • A circRNA-ceRNA regulatory network in osteosarcoma was successfully built.
  • This network plays significant roles in OS pathogenesis.
  • The identified network components may represent important therapeutic targets for osteosarcoma.